These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 788733)

  • 1. The use of isoniazid as a marker to monitor the self-administration of medicaments.
    Stark JE; Ellard GA; Gammon PT; Fox W
    Br J Clin Pharmacol; 1975 Aug; 2(4):355-8. PubMed ID: 788733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A trial of chemoprophylaxis of natural influenza infection with U.K. 2371.
    Stark JE; Heath RB; Oswald NC; Booth V; Tall R; Fox W; Moynagh KD; Inglis JM
    Thorax; 1970 Nov; 25(6):649-55. PubMed ID: 4924346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs.
    Ellard GA; Jenner PJ; Downs PA
    Br J Clin Pharmacol; 1980 Oct; 10(4):369-81. PubMed ID: 7448108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring regularity of drug intake in tuberculous patients by means of simple urine tests.
    Burkhardt KR; Nel EE
    S Afr Med J; 1980 Jun; 57(24):981-5. PubMed ID: 7404075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive urine-test method for monitoring the ingestion of isoniazid.
    Ellard GA; Greenfield
    J Clin Pathol; 1977 Jan; 30(1):84-7. PubMed ID: 838875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field study of U.K.2054 against natural infection with A2-Hong Kong-68 influenza virus.
    Meenan PN; Hillary IB
    Lancet; 1969 Sep; 2(7621):641-2. PubMed ID: 4185613
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring the ingestion of anti-tuberculosis drugs by simple non-invasive methods.
    Sirgel FA; Maritz JS; Venter A; Langdon G; Smith PJ; Donald PR
    Int J Pharm; 2006 Jan; 307(2):182-7. PubMed ID: 16303269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple method for determining isoniazid acetylator phenotype.
    Russell DW
    Br Med J; 1970 Aug; 3(5718):324-5. PubMed ID: 5451955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid and acetylisoniazid kinetics in serum and urine in pulmonary primary complex with intermittent regimen.
    Seth V; Seth SD; Beotra A; Semwal OP; D'monty V; Mukhopadhya S
    Indian Pediatr; 1994 Mar; 31(3):279-85. PubMed ID: 7896362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of subjects as slow or rapid inactivators of isoniazid oral administration of a slow-release preparation of isoniazid and determination of the ratio of acetylisoniazid to isoniazid in urine.
    Kailasam S; Immanuel C; Nair NG; Radhakrishma S; Tripathy SP
    Indian J Med Res; 1975 Feb; 63(2):323-8. PubMed ID: 1213728
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of compliance with antituberculous chemoprophylaxis among recluse population of the Jaen penitentiary center].
    Romero Saldaña M; Vaquero Abellán M; Gallego Rubio R; Aguilera López MD; de Celis Cornejo JM; Barquín García E; Zurita Serrano R
    Rev Esp Salud Publica; 1997; 71(4):391-9. PubMed ID: 9490193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trial of a new anti-myxovirus compound.
    Stark JE
    Thorax; 1969 Jul; 24(4):507. PubMed ID: 4307612
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetic evaluation of aconiazide, a potentially less toxic isoniazid prodrug.
    Peloquin CA; James GT; Craig LD; Kim M; McCarthy EA; Iklé D; Iseman MD
    Pharmacotherapy; 1994; 14(4):415-23. PubMed ID: 7937278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol.
    Schall R; Müller FO; Duursema L; Groenewoud G; Hundt HK; Middle MV; Mogilnicka EM; Swart KJ
    Arzneimittelforschung; 1995 Nov; 45(11):1236-9. PubMed ID: 8929247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attendance versus compliance with tuberculosis treatment in an occupational setting--a pilot study.
    Mqoqi NP; Churchyard GA; Kleinschmidt I; Williams B
    S Afr Med J; 1997 Nov; 87(11):1517-21. PubMed ID: 9472274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of influenza B with UK 2054.
    Meenan PN; Hillary IB
    Lancet; 1969 Sep; 2(7621):614-5. PubMed ID: 4185593
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic trial of a combination of isoniazid, rifampicin and pyrazinamide in the first 2 months of treatment of pulmonary tuberculosis].
    Bellabas M; Khaled S; Khaled NA; Boulahbal F; Chaulet P
    Rev Mal Respir; 1989; 6(1):59-64. PubMed ID: 2648511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.
    Szakacs TA; Wilson D; Cameron DW; Clark M; Kocheleff P; Muller FJ; McCarthy AE
    BMC Infect Dis; 2006 Jun; 6():97. PubMed ID: 16772037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine levels of rifampicin & isoniazid in asymptomatic HIV-positive individuals.
    Ramachandran G; Hemanth Kumar AK; Sarala K; Padmapriyadarsini C; Anitha S; Tharani CB; Kumaraswami V; Swaminathan S
    Indian J Med Res; 2007 Jun; 125(6):763-6. PubMed ID: 17704553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.